Psychedelic Commons
ExploreMethodsAbout
Share your data

Mehtani NJ

Department of Medicine, University of California, San Francisco, CA, USA.

7 papers · ORCID

View
ArticlePsilocybin

Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.

Mehtani NJ, Mian MN, Agin-Liebes G +4

Europe PMC2025
View
ArticleKetamine

Ketamine-Assisted Recovery (KARE): protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks.

Mehtani NJ, Anderson BT, Alexander I +4

Europe PMC2025
View
ArticleMDMA

A systematic review of income and education reporting in psychedelic clinical trials.

Grossman DH, Madden KM, Mehtani NJ +4

Europe PMC2025
View
ArticlePsychedelics

On Minimizing Risk and Harm in the Use of Psychedelics.

Evans J, Aixalà M, Anderson BT +28

Europe PMC2025
View
ArticlePsilocybin

Psilocybin-assisted therapy and HIV-related shame.

Mehtani NJ, Johnson MO, Hendricks PS +2

Europe PMC2024
View
ArticlePsychedelics

Psychedelics in Addiction Treatment-Navigating a Sociopolitical Rift.

Mehtani NJ, Anderson BT, Mitchell JM

Europe PMC2024
View
ArticlePsilocybin

Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.

Thomas KL, Jesse R, Mehtani NJ +2

Europe PMC2024
Psychedelic Commons

The open index of psychedelic research.

Explore

All researchDatasetsTrialsShare your data

About

About the hubMethods & accuracyData sources
© 2026 Psychedelic Commons. Metadata aggregated from open sources; all rights remain with the original authors and publishers.